Biofrontera (BFRI) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.85, +2.05% vs the prior close of $0.83.
- Volume 275.90K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BFRI rises 2.0% to $0.85. Closed at $0.85, +2.05% vs the prior close of $0.83. Day range $0.82–$0.88, opened at $0.82.
BFRI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — BFRI rises 2.0% to $0.85
- Closed at $0.85, +2.05% vs the prior close of $0.83. Day range $0.82–$0.88, opened at $0.82.
- Volume was 275.90K shares, 0.5x its 50-day average of 591.96K — lighter than usual.
- Price is -32.8% vs its 50-day average ($1.26) and -17.8% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 26% of that range, 49.0% below the 52-week high.
Oct 14, 2026 — BFRI slides 7.0% to $0.83, a 3-month low, 3 down days in a row
- Closed at $0.83, -6.95% vs the prior close of $0.89. Day range $0.82–$0.89, opened at $0.88.
- Volume was 347.40K shares, 0.6x its 50-day average of 595.33K — lighter than usual.
- Price is -34.5% vs its 50-day average ($1.27) and -19.4% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 25% of that range, 50.0% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — BFRI slides 3.6% to $0.89
- Closed at $0.89, -3.57% vs the prior close of $0.93. Day range $0.87–$0.94, opened at $0.93.
- Volume was 319.70K shares, 0.5x its 50-day average of 596.53K — lighter than usual.
- Price is -30.1% vs its 50-day average ($1.28) and -13.3% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 30% of that range, 46.3% below the 52-week high.
Oct 12, 2026 — BFRI slides 4.6% to $0.93
- Closed at $0.93, -4.64% vs the prior close of $0.97. Day range $0.93–$1.00, opened at $0.97.
- Volume was 140.20K shares, 0.2x its 50-day average of 602.38K — lighter than usual.
- Price is -27.8% vs its 50-day average ($1.28) and -10.1% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 33% of that range, 44.3% below the 52-week high.
Oct 9, 2026 — BFRI jumps 5.5% to $0.97
- Closed at $0.97, +5.55% vs the prior close of $0.92. Day range $0.91–$1.01, opened at $0.93.
- Volume was 275.20K shares, 0.4x its 50-day average of 612.80K — lighter than usual.
- Price is -24.6% vs its 50-day average ($1.29) and -5.6% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 38% of that range, 41.6% below the 52-week high.
Oct 8, 2026 — BFRI dips 1.7% to $0.92
- Closed at $0.92, -1.71% vs the prior close of $0.94. Day range $0.88–$0.95, opened at $0.94.
- Volume was 231.60K shares, 0.4x its 50-day average of 622.75K — lighter than usual.
- Price is -28.9% vs its 50-day average ($1.29) and -10.4% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 33% of that range, 44.6% below the 52-week high.
Oct 7, 2026 — BFRI rises 0.3% to $0.94
- Closed at $0.94, +0.32% vs the prior close of $0.93. Day range $0.91–$0.98, opened at $0.92.
- Volume was 278.80K shares, 0.4x its 50-day average of 635.09K — lighter than usual.
- Price is -27.9% vs its 50-day average ($1.30) and -8.8% vs its 200-day average ($1.03).
- 52-week range $0.56–$1.66; today's close sits at 34% of that range, 43.7% below the 52-week high.
Oct 6, 2026 — BFRI jumps 4.6% to $0.93
- Closed at $0.93, +4.60% vs the prior close of $0.89. Day range $0.86–$0.95, opened at $0.88.
- Volume was 390.30K shares, 0.6x its 50-day average of 633.43K.
- Price is -28.3% vs its 50-day average ($1.30) and -9.0% vs its 200-day average ($1.02).
- 52-week range $0.56–$1.66; today's close sits at 34% of that range, 43.9% below the 52-week high.
Oct 5, 2026 — BFRI slides 12.2% to $0.89, a 3-month low, 7 down days in a row
- Closed at $0.89, -12.22% vs the prior close of $1.01. Day range $0.88–$1.00, opened at $1.00.
- Volume was 720.90K shares, 1.2x its 50-day average of 622.32K.
- Price is -31.6% vs its 50-day average ($1.30) and -12.9% vs its 200-day average ($1.02).
- 52-week range $0.56–$1.66; today's close sits at 30% of that range, 46.3% below the 52-week high.
- That makes 7 straight losses.
Oct 2, 2026 — BFRI dips 2.4% to $1.01, a 3-month low, 6 down days in a row
- Closed at $1.01, -2.40% vs the prior close of $1.04. Day range $1.00–$1.12, opened at $1.11.
- Volume was 334.70K shares, 0.5x its 50-day average of 618.88K — lighter than usual.
- Price is -22.3% vs its 50-day average ($1.31) and -0.8% vs its 200-day average ($1.02).
- 52-week range $0.56–$1.66; today's close sits at 42% of that range, 38.9% below the 52-week high.
- That makes 6 straight losses.
BFRI latest news & SEC filings
Every SEC filing by or about BFRI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $12.00M (prior year $9.03M) (+32.9% vs Jun 30, 2025)
- Net income: -$604.00K (prior year -$5.32M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.57) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 22, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jul 22, 2026 · Form 10-K/A — Annual report (amended)
Amended annual report
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Things to know before you trade BFRI
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 14, 2026, Mar 19, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.18% (largest 12.2%). That is a volatile stock.
- Liquidity: about 358.46K shares (≈$303.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.85 vs a range of $0.56–$1.66 (26% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 14, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 14.85M shares outstanding (Aug 11, 2026), +39.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BFRI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.82 | 0.88 | 0.82 | 0.85 | 275.90K |
| Oct 14, 2026 | 0.88 | 0.89 | 0.82 | 0.83 | 347.40K |
| Oct 13, 2026 | 0.93 | 0.94 | 0.87 | 0.89 | 319.70K |
| Oct 12, 2026 | 0.97 | 1.00 | 0.93 | 0.93 | 140.20K |
| Oct 9, 2026 | 0.93 | 1.01 | 0.91 | 0.97 | 275.20K |
| Oct 8, 2026 | 0.94 | 0.95 | 0.88 | 0.92 | 231.60K |
| Oct 7, 2026 | 0.92 | 0.98 | 0.91 | 0.94 | 278.80K |
| Oct 6, 2026 | 0.88 | 0.95 | 0.86 | 0.93 | 390.30K |
| Oct 5, 2026 | 1.00 | 1.00 | 0.88 | 0.89 | 720.90K |
| Oct 2, 2026 | 1.11 | 1.12 | 1.00 | 1.01 | 334.70K |
| Oct 1, 2026 | 1.06 | 1.07 | 1.02 | 1.04 | 340.90K |
| Sep 30, 2026 | 1.11 | 1.14 | 1.07 | 1.08 | 284.00K |
| Sep 29, 2026 | 1.10 | 1.14 | 1.08 | 1.09 | 258.10K |
| Sep 28, 2026 | 1.16 | 1.17 | 1.09 | 1.13 | 383.80K |
| Sep 25, 2026 | 1.20 | 1.23 | 1.16 | 1.18 | 247.10K |
| Sep 24, 2026 | 1.16 | 1.23 | 1.14 | 1.20 | 280.50K |
| Sep 23, 2026 | 1.17 | 1.18 | 1.12 | 1.15 | 288.90K |
| Sep 22, 2026 | 1.16 | 1.18 | 1.11 | 1.17 | 476.30K |
| Sep 21, 2026 | 1.32 | 1.32 | 1.14 | 1.16 | 918.80K |
| Sep 18, 2026 | 1.29 | 1.33 | 1.27 | 1.32 | 376.20K |
About Biofrontera
Biofrontera (BFRI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in WOBURN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1858685.
BFRI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John J Iii Borer | Director | Mar 6, 2026 |
| Beth J. Hoffman | Director | Mar 6, 2026 |
| Heikki Lanckriet | Director | Mar 6, 2026 |
| Hermann Luebbert | CEO & Chairman | Jul 29, 2026 |
| Kevin Daniel Weber | Director | Mar 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| George Patrick Jones | Chief Commercial Officer | Mar 6, 2026 |
| Eugene Frederick Leffler | Chief Financial Officer | Jul 29, 2026 |
| Hermann Luebbert | CEO & Chairman | Jul 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BFRI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $41.70M | $-10.54M | -1.04 | $-13.36M |
| Dec 31, 2024 | $37.32M | $-17.76M | -3.22 | $-10.27M |
| Dec 31, 2023 | $34.07M | $-20.13M | -13.02 | $-24.89M |
| Dec 31, 2022 | $28.67M | $-640.00K | -0.61 | $-16.20M |
| Dec 31, 2021 | $24.10M | $-37.71M | — | $-26.71M |
Latest balance sheet: total assets $24.06M, total liabilities $18.11M, cash $4.66M (as of Jun 30, 2026).
BFRI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $1.26 |
| May 14, 2026 | 8-K Item 2.02 (results) | $0.99 |
| Mar 19, 2026 | 8-K Item 2.02 (results) | $0.86 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $0.80 |
| Nov 13, 2025 | 8-K Item 2.02 (results) | $0.89 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $0.95 |
| May 15, 2025 | 8-K Item 2.02 (results) | $0.70 |
| Mar 21, 2025 | 8-K Item 2.02 (results) | $0.86 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $0.83 |
| Aug 14, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| Mar 15, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Vertex Pharmaceuticals Inc / Ma (VRTX)Pfizer (PFE)Bristol Myers Squibb (BMY)Astrazeneca (AZN)Regeneron Pharmaceuticals (REGN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on BFRI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.